Labcorp stock gains on insider grants and a 2026 price rise

Labcorp stock is trading at USD 331.66, up 1.24 percent, while September 1, 2026 grants added fresh executive equity awards.

Labcorp Holdings Inc. (US53223X1072) stock traded at USD 331.66 on September 3, 2026, up 1.24 percent, with a market capitalization of USD 26.898 billion and the Diagnostics & Research industry tag shown in the live quote snapshot.

September 1, 2026 also brought new equity awards: Stock Titan reported a 750 RSU grant to CIO Akinbolade Oyegunwa and a separate 900 RSU award to COO Jonathan Meltzer, both with no price paid per share.

Executive awards in view

The grants add a concrete governance angle to the stock because they were disclosed as insider compensation items, not market purchases. Stock Titan also said one September 1, 2026 award vested in three equal annual installments beginning on September 1, 2027.

For investors, the immediate numbers are still the market quote and the ownership signal: USD 331.66, plus 750 RSUs and 900 RSUs on September 1, 2026.

Market level and valuation

The same live quote snapshot put Labcorp at a market capitalization of USD 26.898 billion. The stock was up 1.24 percent in that view, which gives the article its current price signal as of September 3, 2026.

That combination matters more than a generic reaction note: the quote and the valuation are dated, while the equity awards show a second current datapoint from inside the company.

Labcorp diagnostics focus

Labcorp's Diagnostics and Research business remains the core operating frame behind the stock. The live quote snapshot named the industry as Diagnostics & Research, which matches the company's lab-testing and research-services profile.

That makes the market's next attention point straightforward: follow the business line that links the current quote to the company's clinical and research franchise.

Quote stays current

Labcorp stock traded at USD 331.66 on September 3, 2026, with a gain of 1.24 percent and a market capitalization of USD 26.898 billion in the cited quote snapshot.

The level gives the clearest current reading for the shares, while the September 1, 2026 equity awards add a fresh company-specific detail to the same-day picture.

Labcorp at a glance

• Company: Labcorp Holdings Inc.
• ISIN: US53223X1072
• Ticker: LH
• Trading venue: NYSE
• Price (as of September 3, 2026): USD 331.66
• Market capitalization: USD 26.898 billion (as of September 3, 2026)
• Sector / Industry: Diagnostics & Research